Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VECTICAL | Galderma | N-022087 RX | 2009-01-23 | 1 products, RLD, RS |
ROCALTROL | Validus Pharmaceuticals | N-018044 RX | 1982-01-01 | 2 products, RLD |
ROCALTROL | Validus Pharmaceuticals | N-021068 RX | 1998-11-20 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
calcitriol | ANDA | 2023-12-25 |
calcitrol | NDA authorized generic | 2023-05-15 |
rocaltrol | New Drug Application | 2023-12-15 |
vectical | New Drug Application | 2022-10-31 |
Expiration | Code | ||
---|---|---|---|
CALCITRIOL, VECTICAL, GALDERMA LABS LP | |||
2023-07-17 | NPP |
Code | Description |
---|---|
J0636 | Injection, calcitriol, 0.1 mcg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | 10 | 12 | 9 | 11 | 3 | 42 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | — | 2 | 3 | 9 | 3 | 17 |
Chronic renal insufficiency | D051436 | — | N18 | 1 | — | 3 | 10 | 3 | 17 |
Vitamin d deficiency | D014808 | EFO_0003762 | E55 | 1 | 1 | 1 | 4 | 6 | 13 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 3 | 1 | 2 | 4 | 10 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | 2 | 2 | 3 | 1 | — | 7 |
Neoplasms | D009369 | — | C80 | 6 | — | — | 1 | — | 7 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 1 | 2 | 1 | 1 | 4 |
Chronic kidney disease-mineral and bone disorder | D012080 | EFO_1001152 | N25.0 | — | 2 | — | 2 | — | 4 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | 1 | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 3 | 11 | 2 | — | 1 | 15 |
Hypocalcemia | D006996 | HP_0002901 | E83.51 | — | 3 | 1 | — | 3 | 7 |
Hyperparathyroidism | D006961 | EFO_0008506 | E21.3 | — | — | 1 | — | 2 | 3 |
Adenomatous polyps | D018256 | — | D28 | — | — | 1 | — | — | 1 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | 1 | — | — | 1 |
Angiofibroma | D018322 | EFO_1001761 | — | — | — | 1 | — | — | 1 |
Heart transplantation | D016027 | EFO_0010673 | — | — | — | 1 | — | — | 1 |
Osteopetrosis | D010022 | HP_0011002 | Q78.2 | — | — | 1 | — | — | 1 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | — | — | 1 | 4 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | — | — | 1 | 3 |
Non-small-cell lung carcinoma | D002289 | — | — | 2 | 3 | — | — | — | 3 |
Hypoparathyroidism | D007011 | HP_0000829 | E20 | — | 1 | — | — | 2 | 3 |
Castration-resistant prostatic neoplasms | D064129 | — | — | — | 2 | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 2 | — | — | — | 2 |
Crohn disease | D003424 | EFO_0000384 | K50 | 1 | 1 | — | — | 1 | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 2 | — | — | — | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 2 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | 2 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | 2 | 3 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Cocaine-related disorders | D019970 | — | F14 | 1 | — | — | — | — | 1 |
Hypophosphatemic rickets | D063730 | — | E83.31 | 1 | — | — | — | — | 1 |
Chronic disease | D002908 | — | — | 1 | — | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | — | — | — | — | 1 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | — | — | — | — | 1 |
Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | — | — | — | 2 | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 1 | 1 |
Retinal diseases | D012164 | HP_0000479 | H35.9 | — | — | — | — | 1 | 1 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | — | 1 | 1 |
Allergic contact dermatitis | D017449 | — | L23 | — | — | — | — | 1 | 1 |
Thyroid diseases | D013959 | HP_0000820 | E00-E07 | — | — | — | — | 1 | 1 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Child development | D002657 | — | — | — | — | — | — | 1 | 1 |
Aggressive periodontitis | D010520 | EFO_0006342 | K05.2 | — | — | — | — | 1 | 1 |
Drug common name | Calcitriol |
INN | calcitriol |
Description | Calcitriol is a hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol. It has a role as a bone density conservation agent, an antipsoriatic, an immunomodulator, an antineoplastic agent, a calcium channel modulator, a nutraceutical, a calcium channel agonist, a metabolite, a hormone, a human metabolite and a mouse metabolite. It is a hydroxycalciol, a member of D3 vitamins and a triol. |
Classification | Small molecule |
Drug class | vitamin D analogs |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O |
PDB | — |
CAS-ID | 32222-06-3 |
RxCUI | — |
ChEMBL ID | CHEMBL846 |
ChEBI ID | 17823 |
PubChem CID | 5280453 |
DrugBank | DB00136 |
UNII ID | FXC9231JVH (ChemIDplus, GSRS) |